PTYLTD
    • Free Reports
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Free Reports

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic
  • Insights From Technical Analysis

Insights From Technical Analysis

Elixir Energy (ASX: EXR)

Elixir Energy (ASX: EXR): Lorelle Results Are In, Now Price Must Rebuild Technical Confidence

Aug 5, 2026
Proactive Equities Team

Elixir Energy’s Lorelle-3H result showed encouraging gas flow, but investors still want proof of sustained production, commercial recovery and pipeline access. The sharp chart breakdown leaves EXR oversold, speculative and dependent on October’s retest.

Ramelius Resources (ASX: RMS)

Ramelius Resources (ASX: RMS): Sustained Cash Flow Strength and Production Momentum

Aug 5, 2026
Proactive Equities Team

Ramelius Resources delivers record free cash flow and sustained production growth, reinforcing its position as a high‑grade, low‑cost gold producer with strong shareholder returns and expansion upside.

Global Lithium Resources (ASX: GL1)

Global Lithium Resources (ASX: GL1): Accelerated Integration Toward First Spodumene Production

Aug 3, 2026
Proactive Equities Team

Global Lithium Resources is advancing Manna-Nova integration to target DSO in early 2027 and spodumene concentrate by mid-2027. Nova infrastructure, offtake, prepayment funding and asset-sale proceeds strengthen its pathway to FID, although permitting, funding, execution and lithium-price risks remain.

Iluka Resources (ASX: ILU)

Iluka Resources (ASX: ILU): Rare Earths Execution and Margin Resilience

Jul 27, 2026
Proactive Equities Team

Iluka Resources (ASX: ILU) advances its Eneabba rare earth refinery and Balranald ramp‑up, positioning as Australia’s critical minerals leader with strong government backing and margin resilience through 2026

Larvotto Resources (ASX: LRV)

Larvotto Resources (ASX: LRV): Can Rising Trend Holds as Hillgrove Enters Commissioning?

Jul 27, 2026
Proactive Equities Team

Larvotto Resources enters a key operational phase as Hillgrove commissioning begins, copper expansion progresses, and the weekly chart tests important support and resistance levels while investors watch execution and future growth catalysts.

BLS Pharmaceuticals (ASX: BLS)

BLS Pharmaceuticals' (ASX: BLS) Shares: Strong Growth Story, Crucial Technical Crossroads

Jul 25, 2026
Proactive Equities Team

BLS Pharmaceuticals has rapidly transformed into a profitable regulated-medicines manufacturer, supported by strong revenue growth, controlled-substance licences and international expansion. While FY26 guidance remains ambitious, bearish RSI divergence suggests traders should monitor key support levels closely.

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

12345...30
Page 1 of 30